Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$61,990,290
+$18,694,687 QoQ
Shares Held
1,860,453
+48.6% QoQ
Ownership
2.12%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94.28117775617014.ToString("F0")%
Shared 0.ToString("F0")%
None 5.718822243829863.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. IDYA ranks #46 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in IDYA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,990,290 | 1,860,453 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $43,295,603 | 1,252,404 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $43,001,402 | 1,580,353 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $30,549,980 | 1,453,377 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $27,626,308 | 1,686,588 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $39,965,551 | 1,555,080 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $11,424,975 | 360,637 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $27,530,624 | 784,125 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $33,507,553 | 763,618 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $43,879,779 | 1,233,271 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $6,280,291 | 232,776 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $8,285,299 | 352,566 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,246,021 | 90,752 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,055,982 | 58,117 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $731,553 | 49,032 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,187,557 | 86,055 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,352,185 | 120,839 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $926,520 | 39,193 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $697,991 | 27,383 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $242,601 | 11,558 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $5,428 | 231 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $167,300 | 11,950 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $57,889 | 4,609 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $95,434 | 6,716 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,158 | 524 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||